





Public Health Significance: Asthma is a major public health problem and the most common chronic disease of childhood in the United States. The burden of disease is unequally shared with Puerto Ricans having the highest prevalence, morbidity and mortality from asthma.  Asthma is estimated to cost $56 billion dollars annually in the United States due to cost of treatment, hospitalization and absenteeism from work and school. Better understanding the role of risk factors and potential interventions will be critical in addressing this public health disparity. 
Rationale: Asthma is a multifactorial disease. Understanding the factors contributing to disparities in disease prevalence among Puerto Ricans will provide potential avenues for intervention or prevention. We will accomplish this by examining risk factors including maternal depression, maternal asthma, socioeconomic status and indoor allergen exposure. While maternal depression symptoms and maternal asthma have been separately associated with childhood asthma, no study has estimated their joint effects on asthma in children. Similarly no study has examined the cytokine changes associated with socioeconomic status and whether exposure to cockroach allergen plays a role in that relationship.
Objective: To examine whether maternal depressive symptoms and maternal asthma interact on or have joint effects on childhood asthma. Separately, cytokine profiles as related to socioeconomic status and cockroach allergen exposure will be examined.  
Methods: Cross-sectional study of 655 children (ages 6-14 years) with (n=341) and without (n=314) asthma in San Juan (Puerto Rico). 
Measurements: Maternal depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CESD) Scale questionnaire. A CESD score ≥21 points among the Puerto Rican cohort was used to define significant depressive symptoms.  A maternal history of asthma was defined as the child’s mother ever having asthma. Asthma in participating children was defined as physician-diagnosed asthma and current wheeze. Cytokine levels were measured using a commercially available TH17 cytokine panel. Cockroach and dust mite allergens were measured using a monoclonal antibody assay.  Logistic regression was used for the multivariable analysis. 
Main Results: In a multivariable analysis, children whose mothers had both history of asthma and depressive symptoms had 6.5 times higher odds of asthma (95% confidence interval for the odds ratio=3.3 to 13.0, P <.0001) than children whose mothers had neither history of asthma nor depressive symptoms. In cytokine analysis cockroach allergen (Blatella germanica, Bla g 2) was associated with a mix of TH2 and TH17 related cytokines. Lower socioeconomic status demonstrated a similar profile being associated with increased IL-4, IL-10, IL-17F, IL-25, IL-31 and TNFα as well as decreased IL-17A.  After correction for cockroach allergen (Bla g 2), only increased IL-10 and decreased IL-17A remained significant suggesting that cockroach allergen may have been contributing to previously noted cytokine changes. 
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1.0 	exploring racial/ethnic disparities in childhood asthma
Asthma is the most common chronic disease of childhood and a major public health problem in the United States (U.S.) (1). In this country, the burden of childhood asthma is unequally distributed across racial or ethnic groups, with Puerto Ricans having 20.7% prevalence of asthma compared to non-Hispanic Blacks (14.6%) then non-Hispanic whites (7.5%) or Mexican Americans (5.6%) (Figure 1) (2).  

Figure 1: Asthma prevalence among children of different racial/ethnic groups in the United States

In order to understand the reasons for this observed disparity it becomes important to investigate individual factors associated with asthma.  For this work, maternal depressive symptoms, maternal asthma, socioeconomic status and cockroach allergen exposure will be examined.  Thorough understanding of the relative contributions of risk factors will help to guide treatments and interventions on the individual and population level making best using of public health resources. 
2.0 	Influence of Maternal Depressive Symptoms and maternal asthma on childhood asthma
2.1	Background
Depression is a common mental illness that affects 8-16% of women of reproductive age (3). In particular, depression is frequent during and after pregnancy, affecting 10-15% of all gravid and post-partum mothers (4). Similar to what is observed for asthma, post-partum depression disproportionately affects certain racial or ethnic groups: Hispanic mothers are at highest risk, with an incidence of post-partum depression as high as 35% (5). Among Hispanics, Puerto Rican mothers have twice the risk of mental health disorders (including depression) as Mexican Americans (6).
The high frequency of both depression and asthma in Puerto Rican women of reproductive age may contribute to the high prevalence of asthma in Puerto Rican children. Maternal depression during pregnancy has been associated with increased odds of childhood wheeze (an asthma symptom) from ages 1 to 4 years (odds ratio [OR]=1.5, 95% confidence interval [CI]=1.2-1.8) ADDIN EN.CITE (7), with one study suggesting a dose-response relationship between maternal depressive symptoms during pregnancy and severity of childhood wheeze (8). Maternal history of asthma is one of the strongest risk factors for childhood asthma. Children born to mothers with a history of asthma have up to fivefold higher odds of asthma than those born to mothers without history of asthma (95% CI for OR=1.7-14.9) (9). 
Even though depression and asthma are common in women of reproductive age  ADDIN EN.CITE (3, 10-13), no study has assessed whether maternal depressive symptoms and maternal asthma interact on or have joint effects on the development of childhood asthma. We hypothesized that maternal asthma and maternal depressive symptoms are synergistic risk factors for childhood asthma in Puerto Ricans. We examined this hypothesis in a cohort of Puerto Rican children living in San Juan, Puerto Rico.
2.2	Methods
The methods below describe the subject recruitment, study procedures and statistical analysis employed to determine the odds of childhood asthma among children born to mothers with history of asthma and/or depressive symptoms.
2.2.1	Subject Recruitment
Details on study design and subject recruitment have been previously reported  ADDIN EN.CITE (14, 15). In brief, from March 2009 to June 2010, children were chosen from randomly selected households in the metropolitan area of San Juan (PR), using a multistage probability design. Primary sampling units were randomly selected neighborhood clusters based on the 2000 U.S. Census, and secondary sampling units were randomly selected houses within each primary sampling unit.  A household was eligible if ≥1 resident was a child aged 6 to 14 years old. In households with >1 eligible child, only one child was randomly selected for screening. On the basis of the sampling design, 7,073 households were selected and 6,401 (90.5%) were contacted. Of these 6,401 households, 1,111 had ≥1 child within the age range of the study who met other eligibility criterion (see below). In an effort to reach a target sample size of ~700 children (which would give us ≥90% power to detect an OR ≥2 for exposures with a prevalence ≥25%), we attempted to enroll a random sample (n=783) of these 1,111 children. Parents of 105 of these 783 eligible households refused to participate or could not be reached. There were no significant differences in age, gender, or area of residence between eligible children who did (n=678 [86.6%]) and did not (n=105 [13.4%]) agree to participate.
The main recruitment tool was a screening questionnaire given to parents of children ages 6 to 14 years to obtain information about the child’s general and respiratory health. We selected as cases children who had parental report of physician-diagnosed asthma and wheeze in the previous year. We selected as controls children who had neither parental report of physician-diagnosed asthma nor wheeze in the prior year. All study participants had to have four Puerto Rican grandparents, to ensure their Puerto Rican descent. Of the 678 study participants, 655 (~97%) had complete information on maternal depressive symptoms and were thus included in the current analysis.
2.2.2	Study Procedures 
Study participants completed a protocol that included administration of questionnaires and measurement of height and weight. One of the child’s parents (usually [>93%] the mother) completed a questionnaire that was slightly modified from the one used in the Collaborative Study of the Genetics of Asthma. ADDIN EN.CITE (16) This questionnaire was used to obtain information about the child’s general and respiratory health, socio-demographic characteristics, and family history. Maternal depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CESD), a 20-item questionnaire that has been widely used and validated for epidemiologic studies in the general population. ADDIN EN.CITE (17, 18) The overall CESD score is calculated by summing the scores for each item, and ranges from 0 to 60 points.  Maternal history of asthma was defined as a positive answer to the question: “Has the child’s mother ever had asthma?” Height and weight were measured to the nearest centimeter and pound, respectively.
Written parental consent was obtained for participating children, from whom written assent was also obtained. The study was approved by the Institutional Review Boards of the University of Puerto Rico (San Juan, PR), Brigham and Women’s Hospital (Boston, MA), and the University of Pittsburgh (Pittsburgh, PA).
2.2.3	Statistical Analysis 
Our outcome of interest was asthma in participating children, defined as physician-diagnosed asthma and wheeze in the previous year. Maternal depressive symptoms were considered present if the CESD score was ≥ 21 points, which has been shown to be an adequate cutoff score for significant depressive symptoms in Puerto Rican adults, and to indicate severe depressive symptoms in non-Puerto Rican adults  ADDIN EN.CITE (17, 18).
For each continuous variable, we used two-sample t-tests to compare two groups. For the comparison of each binary variable between two groups, we used chi square tests. For the multivariate analysis, we used a stepwise approach to build the logistic regression models. Because of their well-established association with depression and/or asthma, all final models included age, gender (19), household income (< vs. ≥ $15,000/year [near the median income for households in Puerto Rico in 2008-2009 ]) ADDIN EN.CITE (20-22), early-life exposure (in utero or in the first two years of life) to environmental tobacco smoke (ETS)  ADDIN EN.CITE (23) and maternal history of asthma. Other covariates considered in the initial multivariate models included body mass index (BMI) as a z-score (based on 2000 CDC growth charts), atopy (≥1 positive allergen-specific IgE) and current exposure to ETS; these covariates were removed from the final models, as they were neither associated with asthma at P<0.05 nor changed the parameter estimate (β) for maternal depressive symptoms by ≥10%. After the final multivariate models were built, and on the basis of our a priori hypothesis, we first tested for a first-order interaction (on a multiplicative scale) between maternal depressive symptoms and maternal history of asthma on childhood asthma. Next, we examined the odds of developing childhood asthma among the four possible exposure groups, no maternal asthma and no maternal depressive symptoms, no maternal asthma and maternal depressive symptoms, maternal asthma and no maternal depressive symptoms, and maternal asthma and depressive symptoms. Additive interactions were examined using the Relative Excess Risk due to Interaction (RERI)(24).








Table 1: Main characteristics of study participants – Depressive Symptoms and Asthma
	Controlsn=314	Casesn=341
Age (years)*	10.9 (2.7)	10.4 (2.6) ‡
Male gender	153 (48.7 %)	194 (56.9 %) ‡
Early-life ETS  	122 (38.8 %)	168 (49.3 %) §
Current ETS	107 (34.1 %)	152 (44.6 %) §
Household income >$15,000 per year	110 (36.7 %)	116 (34.6 %)
Maternal Education Level		
Middle School	99 (31.5 %)	108 (31.7 %)
High School	91 (29.0 %)	96 (28.2 %)
Less than 3 years of College	56 (17.8 %)	55 (16.1 %)
3 or more years of College 	68 (21.7 %)	82 (24.1 %)
Maternal Asthma		
 (Self-Report)	66 (21.0 %)	166 (48.7 %) §
Maternal Depression		
Depressive Symptoms (CESD Self-report) 	67 (21.3 %)	96 (28.2 %) ‡
ETS: Environmental Tobacco Smoke. Early-life ETS: In utero or before age 2 years.
Depressive symptoms: A Center for Epidemiologic Studies Depression (CESD) score ≥ 21 points in Puerto Ricans using full CESD
*Data are presented as mean (SDs) for continuous variables or number (percentage) for binary variables.  
‡P-value <0.05 for the comparison between cases and controls by location
§P-value <0.01 for the comparison between cases and controls by location

Table 1 shows the main characteristics of the Puerto Rican participants (n=655). Among the Puerto Rican cohort, children with asthma (cases) were significantly younger and more likely to be male, and more likely to have been exposed to ETS (both in early life and currently), to have a maternal history of asthma and to have a mother with depressive symptoms. There were no significant differences in household income or maternal education attainment between cases and control subjects.
Table 2: Maternal depressive symptoms and asthma among Puerto Rican children
	Unadjusted	Model  1	Model 2
                                                         Odds ratio (95% confidence interval), P value
Maternal depressive symptoms 	1.4 (1.0-2.1), 0.04	1.5 (1.0-2.2), 0.04	1.5 (1.0-2.2), 0.06
Age (years)		0.9 (0.9-1.0), 0.02	0.9 (0.9-1.0), 0.01
Male gender		1.4 (1.0-1.9), 0.05	1.5 (1.1-2.1), 0.02
Household income >$15,000/year		1.2 (0.8-1.6), 0.42	1.2 (0.8-1.7), 0.37
Early-life ETS 		1.6 (1.1-2.2), 0.01	1.5 (1.1-2.1), 0.02
Maternal asthma			    3.5 (2.5-5.1), <.0001
Maternal depressive symptoms: A Center for Epidemiologic Studies Depression (CESD) score ≥ 21 points
     Early-life ETS (environmental tobacco smoke): In utero or before age 2 years
Model 1: Adjusted for age, gender, income and early life tobacco smoke exposure
Model 2: Adjusted for age, gender, income, early life tobacco smoke exposure and maternal asthma


Table 2 shows the results of the multivariate logistic regression analysis of maternal depressive symptoms and asthma among participating children in the Puerto Rican cohort. In the unadjusted analysis, maternal depressive symptoms were significantly associated with 1.4 times higher odds of childhood asthma. After adjustment for age, gender, household income, and early-life ETS, maternal depressive symptoms remained significantly associated with 1.5 times increased odds of childhood asthma (Model 1). Following additional adjustment for a maternal history of asthma, the observed association between maternal depressive symptoms and childhood asthma was nearly unchanged in magnitude but became non-statistically significant (P=0.06, Model 2). We found no significant interaction between maternal depressive symptoms and maternal history of asthma on childhood asthma in a multiplicative scale (P= 0.3, tested in Model 2).

Figure 2: Percentage of Puerto Rican subjects with childhood asthma among four different exposure groups






Table 3: Odds ratio of childhood asthma stratified by maternal history of asthma and maternal depressive symptoms among participating children
	Unadjusted	Adjusted*








Household income > $15,000/year		1.18 (0.82-1.69)
Early-life ETS 		1.48 (1.05-2.09)
Depressive symptoms: A Center for Epidemiologic Studies Depression (CESD) score ≥ 21 points using full CESD. Early-life ETS (environmental tobacco smoke): In utero or before age 2 years
*Adjusted for age, gender, household income and ETS prior to 2 years of age

In the unadjusted analysis, children with history of maternal asthma and children with both history of maternal asthma and maternal depressive symptoms had 3.11 (95% CI = 2.10-4.61) and 6.38 (3.28-12.42) times significantly higher odds of asthma, respectively, than those with neither history of maternal asthma nor maternal depressive symptoms (Table 3). Maternal depressive symptoms in the absence of maternal history of asthma were associated with a 1.18 times higher odds of asthma although this relationship was not statistically significant. These findings were nearly unchanged after adjustment for age, gender, household income and early-life ETS (OR for children with history of maternal asthma of 3.18 (2.12-4.77) and children with both history of maternal asthma and maternal depressive symptoms of 6.47 (3.25-12.89). Relative Excess Risk due to Interaction (RERI) for the adjusted model was 3.016 (-1.37, 7.40) indicating additive interaction is not occurring between history of maternal asthma and maternal depressive symptoms.
2.4	discussion 
Among Puerto Rican children living in the island of Puerto Rico, maternal depressive symptoms were significantly and strongly associated with childhood asthma in the presence of a maternal history of asthma. Compared to children whose mothers had neither depressive symptoms nor a history of asthma, those whose mothers had both depressive symptoms and a history of asthma had 6.5 times increased odds of asthma. To our knowledge, this is the first report of joint detrimental effects of maternal depressive symptoms and maternal asthma on childhood asthma.
Several plausible mechanisms could explain the association between maternal depressive symptoms and childhood asthma  ADDIN EN.CITE (25). First, prenatal stressors such as maternal depression may alter immune balance, with enhanced TH2 immune responses and, ultimately, atopic asthma. Cord blood monocytes taken from stressed mothers demonstrate increased production of TNF-α and IL-8 following microbial challenge, as well as decreased production of IFN-γ and increased production of IL-13 in response to dust-mite allergen  ADDIN EN.CITE (26). TH2 immune differentiation may further promote IL-13 and IL-6 production via increased IL-4 production by CD4+ T cells (27). Secondly, perinatal stressors may lead to lasting alterations in the hypothalamic-pituitary-adrenal (HPA) axis, via changes in the glucocorticoid system. For example, children born to mothers who experience major stressful events such as intimate partner violence or depression have increased glucocorticoid receptor (NR3C1) methylation in peripheral and cord blood monocytes [25-27]. Importantly, these alterations have been associated with decreased response to dexamethasone suppression testing, as well as significantly increased cortisol levels in response to experimental stressors at three months of life (28). Moreover, alterations in glucocorticoid balance have been associated with behavioral issues, wheeze and poor functional status in childhood (29). Thirdly, depressive symptoms may alter the mother’s ability to care for her children. Maternal depression could thus influence asthma in children through poor healthcare utilization (30), decreased breastfeeding (6), and poor maternal attachment (31).  Parental mental illness has been linked to poor asthma management in children, leading to increased risk of hospitalization (29). In general agreement with our findings, a high CES-D score in caregivers has been previously associated with increased asthma morbidity in children (32)
Maternal history of asthma has been shown to be a strong risk factor for childhood asthma in  cross-sectional  (33) and birth cohort studies  ADDIN EN.CITE (9, 34), which have estimated ORs for maternal asthma ranging between 3.3 and 5.0. Consistent with findings from those studies, we found that maternal history of asthma was associated with 3.5 times increased odds of asthma in Puerto Rican children in our study (Table 2). Our results markedly extend those from prior studies, and suggest that maternal depressive symptoms may have more detrimental effects in children who are susceptible to asthma by virtue of their maternal history (e.g. through genetic or epigenetic mechanisms).




3.0 	influence of socioeconomic status and cockroach allergen exposure on th17 related Cytokines
3.1	background
Among the multiple factors associated with asthma, low socioeconomic status (38) and cockroach allergen exposure (39) have been associated with increased asthma prevalence. High asthma prevalence has been associated with low socioeconomic status  ADDIN EN.CITE (38, 40-42). In 2010, asthma prevalence was 11.2% for individuals living below the federal poverty level in the US, compared to 8.7% and 7.3% asthma prevalence for individuals at 100-200% and above 200% of the federal poverty level respectively (42). This relationship persisted in 2013, asthma prevalence was 10.9% for individuals living below the federal poverty level and only 6-7% asthma prevalence for individuals above the poverty line (40).  Higher asthma prevalence among individuals with low socioeconomic status (38) could be due to more stressful life events , more perceived threat from a stressful event  ADDIN EN.CITE (43), increased environmental smoke exposure (38)  or increased exposure to indoor allergens such as cockroach and dust mites (44).
Exposure to cockroach allergen is a proven causative factor for asthma exacerbations (39). Cockroach allergen exposure can influence the development of asthma by causing atopic sensitization through an IgE dependent pathway or can also act through innate immunity (45). Children living in homes with detectable levels of cockroach allergen have 2 times higher odds of sensitization than children living in homes with no detectable cockroach exposure (46). Sensitization to cockroach allergen among inner-city children was 36.8% (47) and even higher among Puerto Rican children (41.5%) (48). In a separate study, cockroach sensitization was significantly higher among high asthma prevalence neighborhoods than low asthma prevalence neighborhoods (49). Clinically, sensitization and exposure to cockroach allergen are important to consider because sensitized and exposure children are 3.4 times more likely to be hospitalized due to asthma and 78% more likely to have an unscheduled medical visit than unexposed children (47). This phenomenon of increased asthma morbidity related to cockroach exposure can even be observed on the neighborhood level by noting the density of housing code violations among a neighborhood accounted for 22% of the variation in asthma related emergency department visits independent of income (50).  
Cockroach allergen exposure is found among all income levels with 63% of homes in the U.S. having detectable levels (51).  However, low socioeconomic status is associated with increased odds of cockroach exposure  ADDIN EN.CITE (51, 52). Homes with annual household income of less than $20,000 were found to have 12 times higher odds of cockroach allergen high enough to be associated with asthma morbidity (51). This relationship holds on the neighborhood level with high poverty areas (>20% of homes falling below the poverty line) having 33 times higher odds of cockroach allegern exposure (44). 
Alterations in cytokine profiles are one proposed mechanism to explain the influence of socioeconomic status and cockroach exposure on the development of asthma (53). We hypothesized that variations in cytokines associated with socioeconomic status may be accounted for by cockroach allergen exposure due to the close relationship between the two factors. To examine this we conducted a cross sectional analysis among Puerto Rican children.
3.2	methods
The methods below describe the subject recruitment, study procedures and statistical analysis employed to determine the changes in TH17 cytokine profile observed among children of lower socioeconomic income and those exposed to cockroach allergen.
3.2.1	Subject Recruitment
Study design and subject recruitment have previously been described  ADDIN EN.CITE (14, 15). A multistage probabilistic sampling design was utilized to recruit 678 children age 6-14 years from the metropolitan area of San Juan, Puerto Rico. 1,111 households were identified using census data, 783 households were contacted regarding study enrollment.  Parents from 105 of the 783 households either declined enrollment or were unable to be reached. There were no significant differences in age, gender or area of residence among children who did (n=678) and did not (n=105) agree to participate.
The main recruitment tool was a screening questionnaire completed by parents of children ages 6 to 14 years focusing on the child’s general and respiratory health.  Asthma cases were defined as children with wheeze in the last 12 months and parental report of physician-diagnosed asthma.  Controls were children with neither wheeze nor parental report of physician-diagnosed asthma.  Puerto Rican descent was verified by confirming study participants had four Puerto Rican grandparents.  Of the 678 study participants, 558 (~82%) had complete information on income and 543 (~80%) had cockroach (Blatella germanica [Bla g 2]) allergen samples and were thus included in the current analysis.
3.2.2	Study Procedures 
Participants completed a study protocol including questionnaires, weight and height measurements and dust sample collection from the home. The questionnaire, a modified version of one utilized in the Collaborative Study of the Genetics of Asthma (54), was completed by one of the child’s parents.  This questionnaire was used to obtain information about the child’s general and respiratory health, socio-demographic characteristics, annual household income, and current exposure to environmental tobacco smoke (ETS) or early life ETS as defined by in utero or before 2 years of age. Dust samples were collected each subject’s home by vacuuming the bedroom, kitchen and living room using a timed protocol. The collected dust was sifted through a metal sieve, resulting in fine dust to be analyzed using monoclonal-antibody multiplex array assays for cockroach (Blatella germanica [Bla g 2]) and dust mite (Der p 1) allergens  ADDIN EN.CITE (55, 56). Genotyping and estimation of African ancestry was accomplished using the Local Ancestry in admixed populations previously described (14).  Fifteen TH17 pathway-related cytokines (IL-1β, IL-4, IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-22, IL-23, IL-25, IL-31, IL-33,IFNγ, soluble CD40 ligand and TNFα) were measured in participant plasma samples using the Bio-Plex Pro Human TH17 cytokine panel on the Bio-Plex HTF system (Bio-Rad Laboratories Inc,. Hercules, California). Undetectable levels were assigned a constant equal to half the lower limit of detection.  All cytokine levels (pg/mL) were log-transformed for data analysis. 
Written parental consent was obtained for participating children, from whom written assent was also obtained. The study was approved by the Institutional Review Boards of the University of Puerto Rico (San Juan, Puerto Rico), Brigham and Women’s Hospital (Boston, Massachusetts), and University of Pittsburgh (Pittsburgh, Pennsylvania). 

3.2.3	Statistical Analysis 
Our primary outcome was the log-transformed plasma cytokine levels. Cockroach allergen (Bla g 2) was analyzed as a continuous variable following log10-transformation with non-detectable levels being assigned a value equal to half the lowest detectable value.  Household income was treated as a binary variable (< vs ≥ $15,000/year [near the median income for households in Puerto Rico in 2008-2009] (22, 57). 
Multivariate linear regression models were created adding covariates in a step-wise fashion.  All statistical analyses were performed with SAS version 9.4 software (SAS Institute, Cary, NC).
3.3	results
Table 4: Main characteristics of study participants – Socioeconomic Status and Cockroach Allergen 
	Controlsn=327	Casesn=351
Age (years)*	10.9 (2.7)	10.4 (2.6) †
Male Gender	159 (48.6%)	201 (57.2%) †
Annual Household Income ≤ $15,000	196 (62.8%)	225 (65.4%)
Log Transformed Cockroach Allergen	0.254 (0.676)	0.314 (0.723)
Log Transformed Dust Mite Allergen	0.644 (0.514)	0.656 (0.505)
Early-life ETS	131 (40.2%)	174 (49.6%) †
Current ETS	113 (34.6%)	155 (44.2%) †
Distance from a Major Roadway (meters)	384 (298)	337 (270) †
African Ancestry (percent)	24.7 (12.5)	25.2 (11.7)

Table 4 shows the main characteristics of the 678 study participants. Children with asthma were significantly more likely to be younger and a higher proportion was male.  Cases were also significantly more likely to have current environmental tobacco smoke exposure (ETS) and ETS prior to 2 years of life as well as living closer to a major roadway. There were no significant differences in household income, percentage of African ancestry, log-transformed cockroach (Bla g 2) allergen or log-transformed dust mite allergen (Der p 1) between cases and control subjects.


Table 5: Bivariate analysis of log-transformed cytokines by covariate
	IL-1	IL-4	IL-6	IL-10	IL-17A	IL-17F	IL-21	IL-22
Age (years)	-0.005 	-0.018 	-0.025† 	-0.028 	-0.015 	-0.037* 	0.005 	-0.022
Male Gender	-0.0005 	0.002 	0.103* 	0.136 	0.0098	0.062 	0.077 	0.134 
Household Income <$15,000	-0.020 	0.217† 	0.084	0.290†	-0.218†	0.278†	0.065	0.047
Bla g 2	0.057	0.298‡	0.099†	0.346‡	-0.244‡	0.284‡	0.180‡ 	0.186†
Der p 1	0.049 	-0.013	0.045	0.125	-0.103	0.051	0.037	0.046
Current ETS	-0.034	-0.053	-0.002	0.010	-0.077	0.086	0.004	-0.061










Distance from a major roadway	0.0001	-0.0001	-0.0004†	-0.0001	-0.0003	-0.00005
African Ancestry	0.0031	0.0008 	0.0003	0.0024	0.004	-0.0008

*p = ≤ 0.05
†p = ≤ 0.01
‡ p = ≤ 0.001
ETS: Environmental Tobacco Smoke






Table 6: Log-transformed Cytokine Level as Predicted by Low Income and Cockroach Allergen Exposure
Cytokine	Covariate	Model A	Model B	Model C	Model D
		n=558	n=543	n=523	n=503
		β Coefficient (95% CI)
IL-1	Low Income	-0.019 (-0.117 - 0.079)	              --	-0.017 (-0.119 - 0.085)	-0.012 (-0.122 - 0.098)
	Cockroach	--	0.060 (-0.006 – 0.126)	0.064 (-0.004 – 0.133)	0.059 (-0.014 – 0.132)
IL-4	Low Income	0.210* (0.043 - 0.377)	--	0.156 (-0.016 - 0.328)	0.151 (-0.032 - 0.334)
	Cockroach	--	0.296‡ (0.183 – 0.408)	0.291‡ (0.175 – 0.407)	0.286‡ (0.165 – 0.407)
IL-6	Low Income	0.069 (-0.028 - 0.165)	--	0.054 (-0.047 - 0.155)	0.049 (-0.059 - 0.158)
	Cockroach	--	0.099† (0.033 – 0.166)	0.104† (0.036 – 0.172)	0.092† (0.020 – 0.163)
IL-10	Low Income	-0.282† (0.103 - 0.461)	--	0.238* (0.053 - 0.422)	0.223* (0.027 - 0.419)
	Cockroach	--	0.351‡ (0.231 – 0.471)	0.331‡ (0.207 – 0.455)	0.332‡ (0.202 – 0.461)
IL-17A	Low Income	-0.227† (-0.377 - -0.076)	--	-0.179* (-0.334 - -0.023)	-0.182* (-0.350 - -0.015)
	Cockroach	--	-0.244‡ (-0.345 - -0.144)	-0.217‡ (-0.321 - -0.112)	-0.205‡ (-0.316 - -0.095)
IL-17F	Low Income	0.254† (0.068  - 0.440)	--	0.188 (-0.005 - 0.380)	0.191 (-0.014 - 0.396)
	Cockroach	--	0.275‡ (0.149 – 0.401)	0.282‡ (0.152 – 0.411)	0.267‡ (0.131 – 0.402)
IL-21	Low Income	0.068 (-0.065 - 0.201)	--	0.036 (-0.101 - 0.174)	0.036 (-0.112 - 0.183)
	Cockroach	--	0.185‡ (0.095 – 0.275)	0.190‡ (0.097 – 0.283)	0.191‡ (0.093 – 0.288)
IL-22	Low Income	0.037 (-0.128 - 0.202)	--	0.018 (-0.154 - 0.190)	0.015 (-0.169 - 0.198)
	Cockroach	--	0.193‡ (0.082 – 0.305)	0.182† (0.066 – 0.298)	0.195† (0.073 – 0.316)
IL-23	Low Income	-0.060 (-0.160 - 0.039)	--	-0.038 (-0.141 - 0.066)	-0.033 (-0.143 - 0.077)
	Cockroach	--	-0.057 (-0.124 – 0.010)	-0.055 (-0.125 – 0.015)	-0.050 (-0.122 – 0.024)
IL-25	Low Income	0.073* (0.002 - 0.144)	--	0.049 (-0.025 - 0.124)	0.045 (-0.035 - 0.126)
	Cockroach	--	0.106‡ (0.057 – 0.154)	0.103‡ (0.053 – 0.153)	0.098‡ (0.045 – 0.151)
IL-31	Low Income	0.201* (0.036 - 0.366)	--	0.157 (-0.016 - 0.329)	0.127 (-0.057 - 0.311)
	Cockroach	--	0.261‡ (0.149 – 0.373)	0.253‡ (0.136 – 0.369)	0.217‡ (0.095 – 0.338)
IL-33	Low Income	-0.019 (-0.144 - 0.106)	--	-0.034 (-0.165 - 0.097)	-0.056 (-0.197 - 0.084)
	Cockroach	--	0.160† (0.076 – 0.244)	0.164‡ (0.075 – 0.252)	0.177‡ (0.084 – 0.270)
IFNg	Low Income	0.148 (-0.047 - 0.343)	--	0.049 (-0.153 - 0.251)	0.035 (-0.181 - 0.251)
	Cockroach	--	0.284‡ (0.152 – 0.417)	0.297‡ (0.161 – 0.433)	0.308‡ (0.164 – 0.450)
TNFa	Low Income	0.043* (0.003 - 0.082)	--	0.034 (-0.008 - 0.076)	0.038 (-0.008 - 0.083)
	Cockroach	--	0.050† (0.021 – 0.079)	0.054‡ (0.026 – 0.082)	0.052‡ (0.023 – 0.082)
*p = ≤ 0.05
†p = ≤ 0.01
‡ p = ≤ 0.001
Model A: Log transformed Cytokine = Household Income, Age, Gender, and Case-Control Status
Model B: Log transformed Cytokine = Log transformed Cockroach Allergen (Bla G 2), Age, Gender, and Case-Control Status
Model C: Log transformed Cytokine = Household Income, Log transformed Cockroach Allergen (Bla G 2), Age, Gender, and Case-Control Status










In this study, we found that lower income was associated with significantly decreased IL-17A and increased IL-4, IL-10, IL-17F, IL-25, IL-31 and TNF-α.  Interestingly, the majority of these cytokine changes, except for IL-10 and IL-17A, lost significance after correcting for exposure to cockroach allergen (Bla g 2).  This might suggest that cockroach allergen exposure may be the mechanism for the association between socioeconomic status and asthma. To our knowledge, this is the first report where associations between socioeconomic status predicting cytokine responses was near completely accounted for by adjustment for cockroach allergen exposure.
Several plausible mechanisms could explain the loss of significance among cytokine and socioeconomic status associations.  Low socioeconomic status may behave in a collinear fashion with cockroach allergen exposure.  As mentioned above, low socioeconomic status (household income <$20,000) is associated with 12 times the odds of having levels of cockroach allergen exposure high enough to cause asthma morbidity when compared to households with income  above $60,000 (51).  There are also other covariates including environmental tobacco smoke exposure and distance from a major roadway that could vary with socioeconomic status, however we did account for these covariates in our fully saturated model with no change in significance. 
Our study was able to replicate some of the previously observed cytokine responses in response to cockroach allergen including a mix of Th2 and Th17 cytokine responses (53). Previous studies of cytokine responses in relation to socioeconomic status were noted to have significant changes in IL-1, IL-6 and TNF-α of which we were only able to replicate changes in TNF-α (58). Our findings importantly highlight the significant contribution of Th17 cytokine responses indicating a response from the innate cellular immunity that may include neutrophil recruitment and pro-inflammatory cytokines. This is plausible based on previous studies indicating that cockroach allergen can act through PAR-2 mechanisms to induce innate cellular immunity (39).
Interestingly, in Model C when lower income was adjusted for cockroach allergen, increased IL-10 and decreased IL-17A were the only significantly associated cytokines remaining. This could be important when considering the role of Th17 cytokines in chronic inflammation and the function these cytokines serve. IL-17A is an important factor in recruitment of neutrophils leading to tissue inflammation. IL-10 plays an important role in downregulating the Th17 pathway response (59). The changes seen with lower income may represent an attempt to reduce inflammation by altering cytokines to reduce Th17 stimulation.
Our study has several strengths, including the ability to adjust for confounding factors (including asthma status, gender, environmental tobacco smoke exposure and distance from a major roadway), and a relatively large sample size. We do however recognize study limitations. First, the cross sectional study design limits our ability to comment on the temporality of exposures. However, cockroach allergen has previously been proven as a causal factor for asthma morbidity (39). We are also limited in our ability to comment on cytokine changes in other T-cell lineages because we elected to utilize a Th-17 cytokine panel. 
In summary, our findings suggest that cytokine differences observed with socioeconomic status can be almost completely accounted for by exposure to cockroach allergen. This study also highlighted the importance of the Th17 pathway in response to cockroach allergen exposure. Further studies examining the role of cockroach abatement on asthma morbidity among this Puerto Rican cohort should be explored in the future.
4.0 	Public health significance
Asthma is a major public health problem especially among Puerto Ricans who have the highest prevalence, morbidity and mortality from asthma. The annual cost of asthma among all asthmatics in the United States has been estimated at $56 billion dollars when accounting for treatment, hospitalization and absenteeism from work or school (60). The health and financial cost make it imperative to consider what individual and population level treatments and policies can be utilized to reduce the clinical and financial burden of asthma.
	Potential treatment for depressive symptoms could include behavioral therapy or pharmacologic measures.  Several considerations will factor in when considering the appropriate treatment modality including concurrent health issues and patient preferences.  Prevalence of depressive symptoms is high among pregnant women, in fact 35% of Hispanic women experience peri-partum depression (5).   Concurrent health issues such as pregnancy can restrict options for pharmacologic therapy.  Studies have revealed associations between infant neurologic irritability and selective serotonin reuptake inhibitors as well as paroxetine and cardiac defects if the medications are taken during pregnancy (61).  When interviewed, Latina mothers affected by depression preferred utilizing their own support systems to the alternative of home nursing visits; pharmacologic treatment would be accepted only in severe cases or after delivery (62).  Beyond the peri-partum period maternal depressive symptoms have been associated with decreased understanding of asthma medication administration, increased number of forgotten doses and increased emergency department usage for asthma care  ADDIN EN.CITE (63, 64).  Because children are dependent on parents for receiving healthcare and medications it is important to recognize caregiver mental health as one factor that can influence childhood asthma.
	Addressing environmental factors including indoor allergens like cockroach allergen are important in addressing asthma.  In fact, addressing environmental factors is the third component of addressing asthma behind treatment and education (65).  Our analysis suggests that cockroach allergen exposure may contribute to changes in Th17 cytokines important in the development of asthma.  Randomized control trials have shown that taking measures to address cockroach exposure including education, insecticide use and professional cleaning were capable of reducing the overall level of cockroach allergen in homes by 86-91% (66).  Cockroach exposures were also more frequent among families living in rental homes making it important for physicians and policymakers to provide families resources to advocate for clean living conditions from landlords (51).  On the neighborhood level, the density of housing code violations was strongly associated with prevalence of asthma again highlighting the opportunities for policymakers to help families renting homes to advocate for timely and appropriate responses to housing code violations (50).

5.0 	Conclusion
There are many factors that contribute to asthma morbidity and mortality.  It is therefore important to study these factors so that we may better understand how they influence asthma and how we can develop policy and treatments that will work on the individual and population level.  Our study has highlighted the importance of the mother child dyad in the association of maternal depressive symptoms and maternal asthma on childhood asthma.  Our study design limits our ability to comment on directionality of this association, however it is clear from the literature that caregiver mental health can influence seeking medical assistance as well as adherence to treatment regimens.  Our study also proposes that cockroach allergen exposure may be a potential mechanism explaining the association of asthma and low socioeconomic status.  This has important implications for policy and potential interventions namely the very different approaches and resources that would be employed to battle poverty versus cockroach abatement.  Further longitudinal study of how these factors contribute to the development of asthma will be important in strengthening the causal relationship.
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